Maryanne Demasi, reports
Subscribe
Sign in
Home
Archive
About
Did the FDA rush to license Pfizer's covid vaccine to enable vaccine mandates?
Internal FDA communications suggest it was part of the deliberation
Maryanne Demasi, PhD
Mar 20
95
6
Share this post
Did the FDA rush to license Pfizer's covid vaccine to enable vaccine mandates?
maryannedemasi.substack.com
Copy link
Twitter
Facebook
Email
New
Top
Community
BREAKING: Did Cochrane sacrifice its researchers to appease critics?
Authors of the latest Cochrane review angered by Cochrane's capitulation to pressure from critics
Maryanne Demasi, PhD
Mar 15
235
12
Share this post
BREAKING: Did Cochrane sacrifice its researchers to appease critics?
maryannedemasi.substack.com
Copy link
Twitter
Facebook
Email
EXCLUSIVE: Whatever happened to Pfizer's covid vaccine trial in pregnant women?
The trial began in 2021. But over a year after the last woman was enrolled, the company just admitted it still doesn't have the data.
Maryanne Demasi, PhD
Feb 23
537
3
Share this post
EXCLUSIVE: Whatever happened to Pfizer's covid vaccine trial in pregnant women?
maryannedemasi.substack.com
Copy link
Twitter
Facebook
Email
A petition to stop FDA misleading doctors about covid-19 vaccines
Experts warn that the FDA is misleading doctors about the safety and efficacy of covid-19 vaccines, denying people the right to informed consent.
Maryanne Demasi, PhD
Feb 19
102
1
Share this post
A petition to stop FDA misleading doctors about covid-19 vaccines
maryannedemasi.substack.com
Copy link
Twitter
Facebook
Email
FDA fails to warn of mRNA vaccine link to MIS-C
There appears to be a double standard in how the FDA handles safety signals for mRNA vaccines compared to alternative vaccine technology. Soon after…
Maryanne Demasi, PhD
Feb 13
95
12
Share this post
FDA fails to warn of mRNA vaccine link to MIS-C
maryannedemasi.substack.com
Copy link
Twitter
Facebook
Email
EXCLUSIVE: Lead author of new Cochrane review speaks out
A no-holds-barred interview with Tom Jefferson
Maryanne Demasi, PhD
Feb 5
688
9
Share this post
EXCLUSIVE: Lead author of new Cochrane review speaks out
maryannedemasi.substack.com
Copy link
Twitter
Facebook
Email
Is the FDA “doubling down” on a failed strategy?
This is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Last Thursday, the FDA…
Maryanne Demasi, PhD
Jan 31
73
16
Share this post
Is the FDA “doubling down” on a failed strategy?
maryannedemasi.substack.com
Copy link
Twitter
Facebook
Email
Response to a critique of our statin analysis
By Maryanne Demasi, PhD, Paula Byrne, PhD, Mark Jones, PhD, Robert DuBroff, MD. On several occasions, we have been asked to respond to a critique of our…
Maryanne Demasi, PhD
Jan 25
527
365
Share this post
Response to a critique of our statin analysis
maryannedemasi.substack.com
Copy link
Twitter
Facebook
Email
See all
Maryanne Demasi, reports
Subscribe
About
Archive
Recommendations
Sitemap
Share this publication
Maryanne Demasi, reports
maryannedemasi.substack.com
Copy link
Twitter
Facebook
Email
Maryanne Demasi, reports
Independent medical journalism
Over 13,000 subscribers
Subscribe
No thanks
By registering you agree to Substack's
Terms of Service
, our
Privacy Policy
, and our
Information Collection Notice
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts